Reaching the unreachable: Pharma marketing in the age of evolving media habits

This roundtable explores how pharma can realign its strategy to ensure visibility, resonance and results in today’s shifting media ecosystem.

Jameson Fleming (Editor, M M + M) and Manu Singh (Chief Data & Innovation Officer, NCM).

As media habits evolve and audiences fragment across screens, pharma marketers are reassessing where and how to show up. Traditional channels face increasing pressure, while new environments — particularly CTV, OTT, and premium video formats like cinema — are gaining ground for their ability to deliver both attention and measurable outcomes. This roundtable explores how pharma can realign its strategy to ensure visibility, resonance and results in today’s shifting media ecosystem.

Note: The MM+M Podcast uses speech-recognition software to generate transcripts, which may contain errors. Please use the transcript as a tool but check the corresponding audio before quoting the podcast.

Listen to the podcast or read the transcript here.